brain peptides
Recently Published Documents


TOTAL DOCUMENTS

131
(FIVE YEARS 1)

H-INDEX

25
(FIVE YEARS 0)

Author(s):  
Mireya L. Borrajo ◽  
María José Alonso

AbstractThere is a growing number of biomolecules, including peptides, proteins, monoclonal antibodies and RNA, that could be potentially used for the treatment of central nervous system (CNS) diseases. However, the realization of their potential is being hampered by the extraordinary difficulties these complex biomolecules have to reach the brain in therapeutically meaningful amounts. Nose-to-brain (N-to-B) delivery is now being investigated as a potential option for the direct transport of biomolecules from the nasal cavity to different brain areas. Here, we discuss how different technological approaches enhance this N-to-B transport, with emphasis on those that have shown a potential for clinical translation. We also analyse how the physicochemical properties of nanocarriers and their modification with cell-penetrating peptides (CPPs) and targeting ligands affect their efficacy as N-to-B carriers for biomolecules. Graphical abstract



2020 ◽  
Author(s):  
Gerard O'Cuinn
Keyword(s):  


Toxins ◽  
2019 ◽  
Vol 11 (2) ◽  
pp. 91 ◽  
Author(s):  
Anita Mikołajczyk ◽  
Dagmara Złotkowska

Bacterial lipopolysaccharide (LPS) can contribute to the pathogenesis and the clinical symptoms of many diseases such as cancer, mental disorders, neurodegenerative as well as metabolic diseases. The asymptomatic carrier state of Salmonella spp. is a very important public health problem. A subclinical single dose of LPS obtained from S. Enteritidis (5 μg/kg, i.v.) was administered to discern the consequences of changes of various brain peptides such as corticotropin-releasing hormone (CRH), gonadotropin-releasing hormone (GnRH), thyrotropin-releasing hormone (TRH), galanin (GAL), neuropeptide Y (NPY), somatostatin (SOM), substance P (SP), and vasoactive intestinal polypeptide (VIP) in selected clinically important brain sections and endocrine glands of the hypothalamic-pituitary-adrenal (HPA), -thyroid (HPT), -ovarian (HPO) axes. The study was conducted on ten immature crossbred female pigs. The brain peptides were extracted from the hypothalamus (medial basal hypothalamus, preoptic area, lateral hypothalamic area, mammillary bodies, and the stalk median eminence), and pituitary gland (adenohypophysis and neurohypophysis) sections and from the ovaries and adrenal and thyroid glands. There was no difference in health status between LPS and the control groups during the period of the experiment. Nevertheless, even a low single dose of LPS from S. Enteritidis that did not result in any clinical symptoms of disease induced dysregulation of various brain peptides, such as CRH, GnRH, TRH, GAL, NPY, SOM, SP, and VIP in selected brain sections of hypothalamus, pituitary gland and in the endocrine glands of the HPA, HPO, and HPT axes. In conclusion, the obtained results clearly show that subclinical LPS from S. Enteritidis can affect the brain chemistry structure and dysregulate bioactive substance from selected brain sections and glands of the neuroendocrine axes. The exact mechanisms by which LPS can influence major neuroendocrine axes are not fully understood and require further studies.



2019 ◽  
Vol 24 (33) ◽  
pp. 3905-3917 ◽  
Author(s):  
Hulya Karatas ◽  
Muge Yemisci ◽  
Emine Eren-Kocak ◽  
Turgay Dalkara




Author(s):  
Ali Sharifloo ◽  
Arash Zibaee ◽  
Jalal Jalali Sendi ◽  
Khalil Talebi Jahroumi ◽  
Abdolrashid Janghorbani


10.2741/e787 ◽  
2017 ◽  
Vol 9 (1) ◽  
pp. 76-88
Author(s):  
Alinne Pereira de Castro
Keyword(s):  


2017 ◽  
Vol 63 (1) ◽  
pp. 27-31 ◽  
Author(s):  
A.A. Yakovlev ◽  
A.A. Lyzhin ◽  
L.G. Khaspekov ◽  
A.B. Guekht ◽  
N.V. Gulyaeva

Cortexin, a drug containing hydrolyzed brain peptides, has long been used in clinics, but the mechanisms of its action remain obscure. We have hypothesized that cortexin-related neuroprotection is associated with the ability of the drug to inhibit brain proteases. Cortexin effectively inhibited brain caspase-8, while its effects on caspase-1, -3, -9, cathepsin B and calpain were much less pronounced or absent. In addition, we isolated a peptide fraction from cortexin holding all the inhibitory capacity of the original drug, but with a much more simple composition. Both cortexin and its fraction prevented neuronal damage in a culture model of glutamate-induced cell death. Neuroprotective effect of Cortexin may be mediated by inhibition of the initiator caspase-8 in the brain.



2016 ◽  
Vol 230-231 ◽  
pp. 67-75 ◽  
Author(s):  
Surbhi ◽  
Ashutosh Rastogi ◽  
Shalie Malik ◽  
Sangeeta Rani ◽  
Vinod Kumar


Sign in / Sign up

Export Citation Format

Share Document